PAR 3.70% 28.0¢ paradigm biopharmaceuticals limited..

Ann: R&D Investor Presentation, page-92

  1. 818 Posts.
    lightbulb Created with Sketch. 328
    WAs just going back through the slides in realtion to Pay-for Use SAS and found a little error in the slides
    Slide 21 has Pay fo Use SAS OA - Q3 CY2021 but it should be CY2022 as it is waiting for "Study_002 has completed recruitment" .. Note recruitment (not results).
    https://hotcopper.com.au/data/attachments/3193/3193770-d8ecefe7e971b5c858d34de13455af83.jpg

    So any delay in the OA_002 (it is scheduled to start end of current quarter) is likely to push Pay-for-SAS OA revenue out. Lets hope the Q's are answered promptly and they have no more as this should allow IND to start at the end of June and not extend the delay.
    You would hope with the number of centres and suffers that recruitment would be the easiest part... Lets hope.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
0.010(3.70%)
Mkt cap ! $97.94M
Open High Low Value Volume
27.0¢ 29.0¢ 27.0¢ $150.8K 538.7K

Buyers (Bids)

No. Vol. Price($)
5 53920 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 28335 1
View Market Depth
Last trade - 16.10pm 14/05/2024 (20 minute delay) ?
Last
27.5¢
  Change
0.010 ( 1.85 %)
Open High Low Volume
27.5¢ 29.0¢ 27.5¢ 67814
Last updated 15.53pm 14/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.